CLDN

Celladon CorpCIK 1305253 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for CLDN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for CLDN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Honig Peter	Director	13	$0	$230.3K	2015-06-04
COOPER GRAHAM K	Director	2	$0	$0	2015-06-04
NARACHI MICHAEL	Director	3	$500.0K	$0	2015-06-04
Alton Gregg H	Director	2	$0	$0	2015-06-04
ZSEBO KRISZTINA M	Chief Executive Officer	25	$0	$4.16M	2015-04-06
LABA REBECQUE J	VP, Finance and Administration	26	$0	$1.34M	2015-04-02
TAKEYA RYAN K	VP, Manufacturing	16	$0	$603.9K	2015-04-01
RUDY JEFFREY J	VP, Clinical Operations	10	$0	$545.2K	2015-01-09
WIKLUND FREDRIK	VP Corp Dvlpmnt & Invs Rltns	3	$160.0K	$0	2015-01-01
Cleveland Paul B	President and CFO	2	$0	$0	2015-01-01
REED ELIZABETH E	VP, General Counsel	2	$0	$0	2015-01-01
Funder Joshua	Director	8	$1.82M	$0	2014-05-20
Yang Patrick Y	Director	3	$0	$0	2014-05-20
PFIZER INC	10% Owner	7	$1.82M	$0	2014-02-04
Lundbeckfond Invest A/S	10% Owner	7	$1.46M	$0	2014-02-04
Kordel Johan	Director	7	$1.46M	$0	2014-02-04
Enterprise Partners Management LLC	10% Owner	9	$1.06M	$0	2014-02-04
Foley Todd	Director	7	$892.9K	$0	2014-02-04
Novartis Bioventures Ltd	10% Owner	7	$1.30M	$0	2014-02-04

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Alton Gregg H	Director	A Award deriv	2015-06-04	2015-06-05	10,000	—	$0	40,000	SEC↗
COOPER GRAHAM K	Director	A Award deriv	2015-06-04	2015-06-05	10,000	—	$0	40,000	SEC↗
Honig Peter	Director	A Award deriv	2015-06-04	2015-06-05	10,000	—	$0	22,800	SEC↗
NARACHI MICHAEL	Director	A Award deriv	2015-06-04	2015-06-05	10,000	—	$0	50,000	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise deriv	2015-04-06	2015-04-07	41,302	—	$0	652,346	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise deriv	2015-04-06	2015-04-07	6,629	—	$0	645,717	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	S Sale	2015-04-06	2015-04-07	41,302	$18.16	$750.0K	9,754	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	S Sale	2015-04-06	2015-04-07	6,629	$18.44	$122.2K	3,125	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise	2015-04-06	2015-04-07	41,302	$1.12	$46.3K	44,427	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise	2015-04-06	2015-04-07	6,629	$8.00	$53.0K	51,056	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise deriv	2015-04-02	2015-04-03	10,000	—	$0	151,738	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise deriv	2015-04-02	2015-04-03	1,012	—	$0	150,726	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise	2015-04-02	2015-04-03	1,012	$8.00	$8.1K	13,907	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise	2015-04-02	2015-04-03	10,000	$1.12	$11.2K	12,895	SEC↗
LABA REBECQUE J	VP, Corporate Operations	S Sale	2015-04-02	2015-04-03	10,000	$17.33	$173.3K	3,907	SEC↗
LABA REBECQUE J	VP, Corporate Operations	S Sale	2015-04-02	2015-04-03	1,012	$16.95	$17.2K	2,895	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise deriv	2015-04-01	2015-04-03	4,444	—	$0	139,574	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise	2015-04-01	2015-04-03	4,444	$1.12	$5.0K	5,876	SEC↗
TAKEYA RYAN K	VP, Manufacturing	S Sale	2015-04-01	2015-04-03	4,444	$19.13	$85.0K	1,432	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise deriv	2015-03-09	2015-03-09	41,302	—	$0	700,277	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise deriv	2015-03-09	2015-03-09	6,629	—	$0	693,648	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise	2015-03-09	2015-03-09	41,302	$1.12	$46.3K	44,427	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise	2015-03-09	2015-03-09	6,629	$8.00	$53.0K	51,056	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	S Sale	2015-03-09	2015-03-09	41,302	$24.81	$1.02M	9,754	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	S Sale	2015-03-09	2015-03-09	6,629	$24.71	$163.8K	3,125	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise deriv	2015-03-06	2015-03-09	10,000	—	$0	165,738	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise deriv	2015-03-06	2015-03-09	4,000	—	$0	161,738	SEC↗
Honig Peter	Director	M Exercise deriv	2015-03-06	2015-03-09	5,000	—	$0	12,800	SEC↗
LABA REBECQUE J	VP, Corporate Operations	S Sale	2015-03-06	2015-03-09	4,000	$22.48	$89.9K	2,895	SEC↗
LABA REBECQUE J	VP, Corporate Operations	S Sale	2015-03-06	2015-03-09	10,000	$23.29	$232.9K	6,895	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise	2015-03-06	2015-03-09	4,000	$8.00	$32.0K	16,895	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise	2015-03-06	2015-03-09	10,000	$1.12	$11.2K	12,895	SEC↗
Honig Peter	Director	S Sale	2015-03-06	2015-03-09	5,000	$25.00	$125.0K	0	SEC↗
Honig Peter	Director	M Exercise	2015-03-06	2015-03-09	5,000	$9.58	$47.9K	5,000	SEC↗
Honig Peter	Director	M Exercise deriv	2015-03-05	2015-03-09	2,200	—	$0	17,800	SEC↗
Honig Peter	Director	M Exercise deriv	2015-03-05	2015-03-09	2,500	—	$0	20,000	SEC↗
Honig Peter	Director	S Sale	2015-03-05	2015-03-09	2,200	$22.29	$49.0K	0	SEC↗
Honig Peter	Director	M Exercise	2015-03-05	2015-03-09	2,500	$11.30	$28.3K	2,500	SEC↗
Honig Peter	Director	M Exercise	2015-03-05	2015-03-09	2,200	$11.30	$24.9K	4,700	SEC↗
Honig Peter	Director	S Sale	2015-03-05	2015-03-09	2,500	$22.50	$56.3K	2,200	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise deriv	2015-03-02	2015-03-03	7,777	—	$0	144,018	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise	2015-03-02	2015-03-03	7,777	$1.12	$8.7K	9,209	SEC↗
TAKEYA RYAN K	VP, Manufacturing	S Sale	2015-03-02	2015-03-03	7,777	$18.48	$143.7K	1,432	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise deriv	2015-02-09	2015-02-10	6,629	—	$0	741,579	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise deriv	2015-02-09	2015-02-10	41,302	—	$0	748,208	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	S Sale	2015-02-09	2015-02-10	41,302	$15.85	$654.6K	9,754	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise	2015-02-09	2015-02-10	41,302	$1.12	$46.3K	44,427	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise	2015-02-09	2015-02-10	6,629	$8.00	$53.0K	51,056	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	S Sale	2015-02-09	2015-02-10	6,629	$15.94	$105.7K	3,125	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise deriv	2015-02-06	2015-02-10	10,000	—	$0	179,738	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise deriv	2015-02-06	2015-02-10	4,000	—	$0	175,738	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise	2015-02-06	2015-02-10	4,000	$8.00	$32.0K	16,895	SEC↗
LABA REBECQUE J	VP, Corporate Operations	S Sale	2015-02-06	2015-02-10	10,000	$16.08	$160.8K	6,895	SEC↗
LABA REBECQUE J	VP, Corporate Operations	S Sale	2015-02-06	2015-02-10	4,000	$16.08	$64.3K	2,895	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise	2015-02-06	2015-02-10	10,000	$1.12	$11.2K	12,895	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise deriv	2015-02-02	2015-02-03	7,777	—	$0	151,795	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise	2015-02-02	2015-02-03	7,777	$1.12	$8.7K	9,209	SEC↗
TAKEYA RYAN K	VP, Manufacturing	S Sale	2015-02-02	2015-02-03	7,777	$16.35	$127.2K	1,432	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	M Exercise deriv	2015-01-09	2015-01-12	10,000	—	$0	181,738	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	M Exercise	2015-01-09	2015-01-12	10,000	$1.12	$11.2K	11,024	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	S Sale	2015-01-09	2015-01-12	10,000	$18.51	$185.1K	1,024	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise deriv	2015-01-07	2015-01-08	20,000	—	$0	189,738	SEC↗
LABA REBECQUE J	VP, Corporate Operations	M Exercise	2015-01-07	2015-01-08	20,000	$1.12	$22.4K	22,895	SEC↗
LABA REBECQUE J	VP, Corporate Operations	S Sale	2015-01-07	2015-01-08	20,000	$17.30	$346.0K	2,895	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise deriv	2015-01-06	2015-01-08	41,302	—	$0	789,510	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise	2015-01-06	2015-01-08	41,302	$1.12	$46.3K	44,427	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	S Sale	2015-01-06	2015-01-08	41,302	$17.51	$723.2K	3,125	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise deriv	2015-01-02	2015-01-05	7,777	—	$0	159,572	SEC↗
TAKEYA RYAN K	VP, Manufacturing	S Sale	2015-01-02	2015-01-05	7,777	$19.88	$154.6K	1,432	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise	2015-01-02	2015-01-05	7,777	$1.12	$8.7K	9,209	SEC↗
WIKLUND FREDRIK	See Remarks	A Award deriv	2015-01-01	2015-01-05	80,000	—	$0	193,243	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	A Award deriv	2015-01-01	2015-01-05	80,000	—	$0	191,738	SEC↗
TAKEYA RYAN K	VP, Manufacturing	A Award deriv	2015-01-01	2015-01-05	72,000	—	$0	167,349	SEC↗
REED ELIZABETH E	VP, General Counsel	A Award deriv	2015-01-01	2015-01-05	72,000	—	$0	142,500	SEC↗
Cleveland Paul B	President and CFO	A Award deriv	2015-01-01	2015-01-05	140,000	—	$0	417,500	SEC↗
LABA REBECQUE J	VP, Finance and Administrati	A Award deriv	2015-01-01	2015-01-05	80,000	—	$0	209,738	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	A Award deriv	2015-01-01	2015-01-05	275,000	—	$0	830,812	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	M Exercise deriv	2014-12-09	2014-12-10	10,000	—	$0	111,738	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise deriv	2014-12-09	2014-12-10	41,302	—	$0	555,812	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	M Exercise	2014-12-09	2014-12-10	10,000	$1.12	$11.2K	10,414	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	S Sale	2014-12-09	2014-12-10	10,000	$15.00	$150.0K	414	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	M Exercise	2014-12-09	2014-12-10	41,302	$1.12	$46.3K	42,833	SEC↗
ZSEBO KRISZTINA M	Chief Executive Officer	S Sale	2014-12-09	2014-12-10	41,302	$15.00	$619.5K	1,531	SEC↗
LABA REBECQUE J	VP, Finance and Administrati	M Exercise deriv	2014-12-05	2014-12-08	20,000	—	$0	129,738	SEC↗
LABA REBECQUE J	VP, Finance and Administrati	S Sale	2014-12-05	2014-12-08	20,000	$12.77	$255.4K	691	SEC↗
LABA REBECQUE J	VP, Finance and Administrati	M Exercise	2014-12-05	2014-12-08	20,000	$1.12	$22.4K	20,691	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise deriv	2014-12-01	2014-12-02	7,777	—	$0	95,349	SEC↗
TAKEYA RYAN K	VP, Manufacturing	S Sale	2014-12-01	2014-12-02	7,777	$12.01	$93.4K	577	SEC↗
TAKEYA RYAN K	VP, Manufacturing	M Exercise	2014-12-01	2014-12-02	7,777	$1.12	$8.7K	8,354	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	M Exercise deriv	2014-11-14	2014-11-18	18,000	—	$0	121,738	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	M Exercise	2014-11-14	2014-11-18	18,000	$1.12	$20.2K	18,000	SEC↗
RUDY JEFFREY J	VP, Clinical Operations	S Sale	2014-11-14	2014-11-18	18,000	$11.67	$210.1K	0	SEC↗
Cleveland Paul B	President and CFO	A Award deriv	2014-06-19	2014-06-20	277,500	—	$0	277,500	SEC↗
REED ELIZABETH E	VP, General Counsel	A Award deriv	2014-06-09	2014-06-11	65,000	—	$0	65,000	SEC↗
WIKLUND FREDRIK	See Remarks	A Award deriv	2014-05-28	2014-05-29	10,000	—	$0	10,000	SEC↗
Funder Joshua	Director	A Award deriv	2014-05-20	2014-05-21	10,000	—	$0	10,000	SEC↗
Honig Peter	Director	A Award deriv	2014-05-20	2014-05-21	10,000	—	$0	10,000	SEC↗
Yang Patrick Y	Director	A Award deriv	2014-05-20	2014-05-21	10,000	—	$0	10,000	SEC↗
NARACHI MICHAEL	Director	A Award deriv	2014-05-20	2014-05-21	10,000	—	$0	10,000	SEC↗
Alton Gregg H	Director	A Award deriv	2014-05-20	2014-05-21	10,000	—	$0	10,000	SEC↗
COOPER GRAHAM K	Director	A Award deriv	2014-05-20	2014-05-21	10,000	—	$0	10,000	SEC↗
LABA REBECQUE J	VP Finance & Administration	A Award deriv	2014-03-19	2014-03-20	10,000	—	$0	10,000	SEC↗
Honig Peter	Director	A Award deriv	2014-03-02	2014-03-04	10,000	—	$0	10,000	SEC↗
Honig Peter	Director	A Award deriv	2014-03-02	2014-03-04	2,500	—	$0	2,500	SEC↗
Yang Patrick Y	Director	A Award deriv	2014-03-02	2014-03-04	2,500	—	$0	2,500	SEC↗
Yang Patrick Y	Director	A Award deriv	2014-03-02	2014-03-04	10,000	—	$0	10,000	SEC↗
Enterprise Partners Management	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	20,833	—	$0	20,833	SEC↗
Enterprise Partners Management	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	260,859	—	$0	0	SEC↗
Enterprise Partners Management	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	13,553	$8.00	$108.4K	0	SEC↗
Enterprise Partners Management	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	5,741,267	—	$0	0	SEC↗
Enterprise Partners Management	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	11,573,520	—	$0	0	SEC↗
Funder Joshua	Director	C Conversion deriv	2014-02-04	2014-02-06	11,788,047	—	$0	0	SEC↗
Funder Joshua	Director	C Conversion deriv	2014-02-04	2014-02-06	23,145	$8.00	$185.2K	0	SEC↗
Funder Joshua	Director	C Conversion deriv	2014-02-04	2014-02-06	672,060	—	$0	0	SEC↗
Funder Joshua	Director	C Conversion deriv	2014-02-04	2014-02-06	53,807	—	$0	53,807	SEC↗
Kordel Johan	Director	C Conversion deriv	2014-02-04	2014-02-06	18,605	$8.00	$148.8K	0	SEC↗
Kordel Johan	Director	C Conversion deriv	2014-02-04	2014-02-06	358,049	—	$0	0	SEC↗
Kordel Johan	Director	C Conversion deriv	2014-02-04	2014-02-06	28,666	—	$0	28,666	SEC↗
Kordel Johan	Director	C Conversion deriv	2014-02-04	2014-02-06	19,289,531	—	$0	0	SEC↗
Lundbeckfond Invest A/S	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	358,049	—	$0	0	SEC↗
Lundbeckfond Invest A/S	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	28,666	—	$0	28,666	SEC↗
Lundbeckfond Invest A/S	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	19,289,531	—	$0	0	SEC↗
Lundbeckfond Invest A/S	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	18,605	$8.00	$148.8K	0	SEC↗
Novartis Bioventures Ltd	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	25,481	—	$0	25,481	SEC↗
Novartis Bioventures Ltd	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	318,266	—	$0	0	SEC↗
Novartis Bioventures Ltd	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	16,537	$8.00	$132.3K	0	SEC↗
Novartis Bioventures Ltd	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	17,146,250	—	$0	0	SEC↗
PFIZER INC	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	532,818	—	$0	0	SEC↗
PFIZER INC	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	19,289,531	—	$0	0	SEC↗
PFIZER INC	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	42,659	—	$0	42,659	SEC↗
PFIZER INC	10% Owner	C Conversion deriv	2014-02-04	2014-02-06	23,145	$8.00	$185.2K	0	SEC↗
Foley Todd	Director	C Conversion deriv	2014-02-04	2014-02-06	11,788,047	—	$0	0	SEC↗
Foley Todd	Director	C Conversion deriv	2014-02-04	2014-02-06	17,517	—	$0	17,517	SEC↗
Foley Todd	Director	C Conversion deriv	2014-02-04	2014-02-06	218,806	—	$0	0	SEC↗
Foley Todd	Director	C Conversion deriv	2014-02-04	2014-02-06	11,370	$8.00	$91.0K	0	SEC↗
Enterprise Partners Management	10% Owner	C Conversion	2014-02-04	2014-02-06	13,553	$8.00	$108.4K	1,817,101	SEC↗
Enterprise Partners Management	10% Owner	C Conversion	2014-02-04	2014-02-06	926,621	—	$0	1,343,880	SEC↗
Enterprise Partners Management	10% Owner	C Conversion	2014-02-04	2014-02-06	459,668	—	$0	1,803,548	SEC↗
Enterprise Partners Management	10% Owner	P Buy	2014-02-04	2014-02-06	133,083	$8.00	$1.06M	1,950,184	SEC↗
Funder Joshua	Director	C Conversion	2014-02-04	2014-02-06	943,798	—	$0	943,798	SEC↗
Funder Joshua	Director	P Buy	2014-02-04	2014-02-06	227,261	$8.00	$1.82M	1,194,204	SEC↗
Funder Joshua	Director	C Conversion	2014-02-04	2014-02-06	23,145	$8.00	$185.2K	966,943	SEC↗
Kordel Johan	Director	P Buy	2014-02-04	2014-02-06	182,681	$8.00	$1.46M	1,745,683	SEC↗
Kordel Johan	Director	C Conversion	2014-02-04	2014-02-06	1,544,397	—	$0	1,544,397	SEC↗
Kordel Johan	Director	C Conversion	2014-02-04	2014-02-06	18,605	$8.00	$148.8K	1,563,002	SEC↗
Lundbeckfond Invest A/S	10% Owner	P Buy	2014-02-04	2014-02-06	182,681	$8.00	$1.46M	1,745,683	SEC↗
Lundbeckfond Invest A/S	10% Owner	C Conversion	2014-02-04	2014-02-06	18,605	$8.00	$148.8K	1,563,002	SEC↗
Lundbeckfond Invest A/S	10% Owner	C Conversion	2014-02-04	2014-02-06	1,544,397	—	$0	1,544,397	SEC↗
NARACHI MICHAEL	Director	P Buy	2014-02-04	2014-02-06	62,500	$8.00	$500.0K	62,500	SEC↗
Novartis Bioventures Ltd	10% Owner	C Conversion	2014-02-04	2014-02-06	1,372,798	—	$0	1,372,798	SEC↗
Novartis Bioventures Ltd	10% Owner	P Buy	2014-02-04	2014-02-06	162,386	$8.00	$1.30M	1,551,721	SEC↗
Novartis Bioventures Ltd	10% Owner	C Conversion	2014-02-04	2014-02-06	16,537	$8.00	$132.3K	1,389,335	SEC↗
PFIZER INC	10% Owner	C Conversion	2014-02-04	2014-02-06	1,544,397	—	$0	1,544,397	SEC↗
PFIZER INC	10% Owner	C Conversion	2014-02-04	2014-02-06	23,145	$8.00	$185.2K	1,567,542	SEC↗
PFIZER INC	10% Owner	P Buy	2014-02-04	2014-02-06	227,261	$8.00	$1.82M	1,794,803	SEC↗
WIKLUND FREDRIK	VP Corp Dvlpmnt & Invs Rltns	P Buy	2014-02-04	2014-02-06	20,000	$8.00	$160.0K	20,000	SEC↗
Foley Todd	Director	C Conversion	2014-02-04	2014-02-06	11,370	$8.00	$91.0K	955,167	SEC↗
Foley Todd	Director	C Conversion	2014-02-04	2014-02-06	943,797	—	$0	943,797	SEC↗
Foley Todd	Director	P Buy	2014-02-04	2014-02-06	111,608	$8.00	$892.9K	1,066,775	SEC↗